Clinical Trial Update: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial of PF-08653944 in adults with obesity and type 2 diabetes; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-08653944

Snippet

Sponsor: Pfizer | Conditions: Obesity, Overweight and/or Obesity | Phase 3 | Status: RECRUITING